Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group-Reference-Cited by-同舟云学术

Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group

Published:2023-05-12 Issue: Volume:13 Page:
ISSN:2047-2978
Container-title:Journal of Global Health
language:
Short-container-title:J Glob Health

Author:

Cazé Ana B¹,Cerqueira-Silva Thiago²,Bomfim Adriele P¹²,de Souza Gisley L³,Azevedo Amanda CA⁴,Brasil Michelle QA¹²,Santos Nara R⁵,Khouri Ricardo¹²⁶,Dan Jennifer⁷⁸,Bandeira Antonio C⁹¹⁰,Cavalcanti Luciano PG¹¹¹²,Barral-Netto Manoel¹²,Barral Aldina²¹³,Barbosa Cynara G¹,Boaventura Viviane S¹²

Affiliation:

1. Federal University of Bahia, Salvador, Bahia, Brazil

2. Gonçalo Moniz Institute, Fiocruz, Salvador, Bahia, Brazil

3. Bahia School of Medicine and Public Health, Salvador, Bahia, Brazil

4. Santa Izabel Hospital, Santa Casa da Bahia, Salvador, Bahia, Brazil

5. Department of Health Surveillance/Epidemiological Surveillance, Campo Formoso, Bahia Brazil

6. Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Clinical and Epidemiological Virology, Belgium

7. Center for Infectious Disease and Vaccine Research, la Jolla Institute for Immunology (LJI), San Diego (UCSD), California, USA

8. Department of Medicine, Division of Infectious Disease and Global Public Health, University of California, San Diego (UCSD), California, USA

9. Faculty of Technology and Sciences of Salvador, Salvador, Bahia, Brazil

10. Central State Laboratory Lacen/BA, Salvador, Bahia, Brazil

11. Federal University of Ceará, Ceará, Brazil

12. Christus University Center, Fortaleza, Ceará, Brazil

13. Institute for Research in Immunology, São Paulo, São Paulo, Brazil

Publisher

International Society of Global Health

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference38 articles.

1. Global Prevalence of Post- Coronavirus Disease (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.;Chen;J Infect Dis,2022

2. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.;Nasserie;JAMA Netw Open,2021

3. United States Centers for Disease Control and Prevention. Nearly One in Five American Adults Who Have Had COVID-19 Still Have ‘’Long COVID’’. 2022. Available: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm. Accessed: 17 September 2022.

4. Symptoms and risk factors for long COVID in non-hospitalized adults.;Subramanian;Nat Med,2022

5. Causation or confounding: why controls are critical for characterizing long COVID.;Amin-Chowdhury;Nat Med,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An ecological comparison to inspect the aftermath of post COVID-19 condition in Italy and the United States;Scientific Reports;2024-08-21

2. Gender Disparities in Neurological Symptoms of Long COVID: A Systematic Review and Meta-Analysis;Neuroepidemiology;2024-08-19

3. Characterizing health-related quality of life and identifying disease predictors among patients suspected of having long COVID: an analysis of COMET-ICE clinical trial data;Frontiers in Public Health;2024-05-09

4. Proposal and Definition of an Intelligent Clinical Decision Support System Applied to the Prediction of Dyspnea after 12 Months of an Acute Episode of COVID-19;Biomedicines;2024-04-12

5. Characteristics and burden of acute COVID-19 and long-COVID: Demographic, physical, mental health, and economic perspectives;PLOS ONE;2024-01-22